Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 434-444

  Gironès, Núria ^a   Carrasco Marin, Eugenio ^b   Cuervo, Henar ^a   Guerrero, Néstor Adrián ^a   Sanoja, Cristina ^a   Sparrow, John ^c   Flores Herráez, Reyes ^d   Fernández Prieto, Lorena ^d   Chico Calero, Isabel ^a   Salgado, Hugo ^a   Carrión, Javier ^a   Fresno, Manuel ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c Glaxo SmithKline   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Autoimmunity; Autoreactive T cells; Chagas disease; T. Cruzi

Indexed keywords

AUTOIMMUNITY; CELL TRANSFER; CELLULAR IMMUNITY; CHAGAS DISEASE; CONFERENCE PAPER; CROSS REACTION; HUMAN; IMMUNOCOMPETENT CELL; MOLECULAR MIMICRY; NONHUMAN; T LYMPHOCYTE; TRYPANOSOMA CRUZI; ANIMAL; ARTICLE; IMMUNOLOGY; PARASITOLOGY; PATHOLOGY;

MAMMALIA; MUS; TRYPANOSOMA CRUZI;

EPITOPE;

ANIMALS; AUTOIMMUNITY; CHAGAS DISEASE; EPITOPES; HUMANS; MOLECULAR MIMICRY; T-LYMPHOCYTES; TRYPANOSOMA CRUZI;

EID: 34648837663     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.046     Document Type: Conference Paper

References (73)

1. CHAGAS, C. 1909. Nova tripanozomiaze humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schitrypanum cruzi n. gen., n. sp. Ajente etiolojico de nova entidade morbida do homen. Mem. Inst. Oswaldo. Cruz. 1: 159-219.
2. TANOWITZ, H.B. et al. 1992. Chagas' disease. Clin. Microbiol. Rev. 5: 400-419.
3. PRATA, A. 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1: 92-100.
4. MONCAYO, A. 1999. Progress towards interruption of transmission of Chagas disease. Mem. Inst. Oswaldo. Cruz. 94(Suppl. 1): 401-404.
5. BURLEIGH, B.A. & N.W. ANDREWS. 1998. Signaling and host cell invasion by Trypanosoma cruzi. Curr. Opin. Microbiol. 1: 461-465.
6. KIRCHHOFF, L.V. 1989. Is Trypanosoma cruzi a new threat to our blood supply? Ann. Intern. Med. 111: 773-775.
7. WENDEL, S. 1998. Transfusion-transmitted Chagas' disease. Curr. Opin. Hematol. 5: 406-411.
8. GIRONES, N. et al. 2006. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma. Vox Sang. 91: 285-291.
9. KIRCHHOFF, L.V. 1993. Chagas disease. American trypanosomiasis. Infect. Dis. Clin. North Am. 7: 487-502.
10. DIAS, E. et al. 1956. Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation 14: 1035-1060.
11. PRATA, A. 1994. Chagas' disease. Infect. Dis. Clin. North Am. 8: 61-76.
12. ALTCHEH, J. et al. 2005. Congenital Chagas disease: experience in the Hospital de Ninos, Ricardo Gutierrez, Buenos Aires, Argentina. Rev. Soc. Bras. Med. Trop. 38(Suppl. 2): 41-45.
13. SUAREZ, E. et al. 2005. Integral treatment of congenital Chagas disease: the Bolivian experience. Rev. Soc. Bras. Med. Trop. 38(Suppl. 2): 21-23.
14. DOS SANTOS, C.D., M.P. TOLDO & J.C. DO PRADO, JR. 2005. Trypanosoma cruzi: the effects of dehydroepiandrosterone (DHEA) treatment during experimental infection. Acta Trop. 95: 109-115.
15. LO PRESTI, M.S. et al. 2004. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice. Int. J. Antimicrob. Agents 23: 634-636.
16. MEIRA, W.S. et al. 2004. Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients. J. Clin. Microbiol. 42: 707-712.
17. NAKAYAMA, H. et al. 2001. Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline. Phytother. Res. 15: 630-632.
18. SILVA, D.T. et al. 2006. Cytoskeleton reassembly in cardiomyocytes infected by Trypanosoma cruzi is triggered by treatment with ergosterol biosynthesis inhibitors. Int. J. Antimicrob. Agents 27: 530-537.
19. FUJIMURA, A.E. et al. 2001. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect. Immun. 69: 5477-5486.
20. MACHADO, A.V. et al. 2006. Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase. Hum. Gene Ther. 17: 898-908.
21. MIYAHIRA, Y. et al. 2005. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection. Infect. Immun. 73: 7356-7365.
22. MORELL, M. et al. 2006. The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection. Vaccine 24: 7046-7055.
23. VASCONCELOS, J.R. et al. 2004. Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Hum. Gene Ther. 15: 878-886.
24. ENGMAN, D.M. & J.S. LEON. 2002. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop. 81: 123-132.
25. GIRONES, N., H. CUERVO & M. FRESNO. 2005. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr. Top Microbiol. Immunol. 296: 89-123.
26. GIRONES, N. & M. FRESNO. 2003. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol. 19: 19-22.
27. ANDRADE, Z.A. & S.G. ANDRADE. 1955. The pathology of Chagas' disease (cardiac chronic form). Bol. Fund G Moniz. 6: 1-53.
28. MAZZA, S. 1949. La enfermedad de Chagas en la Rep. Argentina. Mem Inst. Oswaldo. Cruz. 47: 273-288.
29. TARLETON, R.L. 2003. Chagas disease: a role for autoimmunity? Trends Parasitol. 19: 447-451.
30. KIERSZENBAUM, F. 1986. Autoimmunity in Chagas' disease. J. Parasitol. 72: 201-211.
31. SOARES, M.B., L. PONTES-DE-CARVALHO & R. RIBEIRO-DOS-SANTOS. 2001. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An. Acad. Bras. Cienc. 73: 547-559.
32. TARLETON, R.L. 2001. Parasite persistence in the aetiology of Chagas disease. Int. J. Parasitol. 31: 550-554.
33. KIERSZENBAUM, F. 1999. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 12: 210-223.
34. LEVIN, M.J. 1996. In chronic Chagas heart disease, don't forget the parasite. Parasitol. Today 12: 415-416.
35. KIERSZENBAUM, F. 2003. Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol. Med. Microbiol. 37: 1-11.
36. HYLAND, K.V. & D.M. ENGMAN. 2006. Further thoughts on where we stand on the autoimmunity hypothesis of Chagas disease. Trends Parasitol. 22: 101-102; author reply 103.
37. ACOSTA, A.M. & C.A. SANTOS-BUCH. 1985. Autoimmune myocarditis induced by Trypanosoma cruzi. Circulation 71: 1255-1261.
38. MCCORMICK, T.S. & E.C. ROWLAND. 1989. Trypanosoma cruzi: cross-reactive anti-heart autoantibodies produced during infection in mice. Exp. Parasitol. 69: 393-401.
39. TAKLE, G.B. & L. HUDSON. 1989. Autoimmunity and Chagas' disease. Curr. Top Microbiol. Immunol. 145: 79-92.
40. COSSIO, P.M. et al. 1974. Chagasic cardiopathy. Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures. Circulation 49: 13-21.
41. COSSIO, P.M. et al. 1974. Chagasic cardiopathy. Antibodies reacting with plasma membrane of striated muscle and endothelial cells. Circulation 50: 1252-1259.
42. SANTOS-BUCH, C.A. & A.R. TEIXEIRA. 1974. The immunology of experimental Chagas' disease. 3. Rejection of allogeneic heart cells in vitro. J. Exp. Med. 140: 38-53.
43. WOOD, J.N. et al. 1982.Amonoclonal antibody defining antigenic determinants on subpopulations of mammalian neurons and Trypanosoma cruzi parasites. Nature 296: 34-38.
44. COSSIO, P.M. et al. 1984. Experimental myocarditis induced in Swiss mice by homologous heart immunization resembles chronic experimental Chagas' heart disease. Clin. Immunol. Immunopathol. 33: 165-175.
45. EISEN, H. & S. KAHN. 1991. Mimicry in Trypanosoma cruzi: fantasy and reality. Curr. Opin. Immunol. 3: 507-510.
46. LEON, J.S. & D.M. ENGMAN. 2001. Autoimmunity in Chagas heart disease. Int. J. Parasitol. 31: 555-561.
47. TARLETON, R.L. & L. ZHANG. 1999. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol. Today 15: 94-99.
48. BENOIST, C. & D. MATHIS. 2001. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2: 797-801.
49. CUNHA-NETO, E. et al. 2006. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39: 41-54.
50. PADILLA, A. et al. 2007. Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells. Infect. Immun. 75: 231-235.
51. ALBAREDA, M.C. et al. 2006. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int. Immunol. 18: 465-471.
52. MARTIN, D.L. et al. 2006. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2: e77.
53. KOTNER, J. & R. TARLETON. 2006. Endogenous CD4+CD25+ regulatory T cells have limited role in control of Trypanosoma cruzi infection in mice. Infect. Immun. 75: 861-869.
54. MARTIN, D.L. & R.L. TARLETON. 2005. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J. Immunol. 174: 1594-1601.
55. MARTIN, D. & R. TARLETON. 2004. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol. Rev. 201: 304-317.
56. LAUCELLA, S.A. et al. 2004. Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J. Infect. Dis. 189: 909-918.
57. LEAVEY, J.K. & R.L. TARLETON. 2003. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J. Immunol. 170: 2264-2268.
58. RIBEIRO-DOS-SANTOS, R. et al. 2001. A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Parasite Immunol. 23: 93-101.
59. CUNHA-NETO, E. et al. 1995. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc. Natl. Acad. Sci. USA 92: 3541-3545.
60. TARLETON, R.L., L. ZHANG & M.O. DOWNS. 1997. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. USA 94: 3932-3937.
61. RIBEIRO DOS SANTOS, R. et al. 1992. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J. Exp. Med. 175: 29-39.
62. CUNHA-NETO, E. et al. 1996. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J. Clin. Invest. 98: 1709-1712.
63. ABEL, L.C., J. KALIL & E. CUNHA NETO. 1997. Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin. Braz. J. Med. Biol. Res. 30: 1305-1308.
64. ABEL, L.C. et al. 2001. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J. Autoimmun. 17: 99-107.
65. PONTES-DE-CARVALHO, L. et al. 2002. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J. Autoimmun. 18: 131-138.
66. LEON, J.S., K. WANG & D.M. ENGMAN. 2003.Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease. J. Immunol. 171: 4271-4277.
67. LEON, J.S. et al. 2001. Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect. Immun. 69: 5643-5649.
68. GIRONES, N. et al. 2001. Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. J. Clin. Invest. 107: 985-993.
69. GIRONES, N. et al. 2001. Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease. Clin. Diagn. Lab. Immunol. 8: 1039-1043.
70. EL-SAYED, N.M. et al. 2005. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309: 409-415.
71. KIERSZENBAUM, F. 2005. Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol. 21: 513-516.
72. ABEL, L.C. et al. 2005. T cell epitope characterization in tandemly repetitive Trypanosoma cruzi B13 protein. Microbes Infect. 7: 1184-1195.
73. IWAI, L.K. et al. 2005. T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J. Autoimmun. 24: 111-117.